ICPT Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.

$19.30  -1.45 (-6.99%)
As of 03/04/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
10/11/2012
33,015,614
954,740
$685,073,991
0.00%
SEC Edgar Online
10-Q
10-K
45845P108
US45845P1084
B7N59F8

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-2.49
13.23
2.19
164.74%
-87.91%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy